EUVIMEDEUVIMED entdecken
Crossref

1024-OR: Immunologically Distinct Type 1 Diabetes Subgroups Exhibit Divergent Metabolomic Profiles

AMINA BEDRAT, NATHAN A. TRUCHAN, SHUANG JIA, MARK ROETHLE, MARTIN J. HESSNER

Diabetes · 05.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-1024-or ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von AMINA BEDRAT und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: The concept of endotypes, disease subgroups with distinct pathomechanisms, offers a framework to explain biological and therapeutic response variability in T1D. We previously identified two age-independent, immunologically distinct T1D subgroups. Subgroup 1 exhibited elevated plasma cytokine/chemokine levels, increased circulating Th1 T-cells, and a better therapeutic response to anti-CD20. Subgroup 2 had elevated levels of plasma microRNAs and a better therapeutic response to CTLA4-Ig that was associated with reductions in central memory T-cells and preservation of regulatory T-cells. Here, we analyzed plasma metabolomic profiles of these two subgroups.

Methods

A cohort of individuals with new onset T1D were recruited (n=47, age=11.6 years, male=53%). Participants were assigned to subgroups using an established plasma-induced transcription assay and classification analyses with 97% accuracy. Untargeted plasma metabolomics utilized liquid chromatography-tandem mass-spectrometry. Pathway analysis utilized IPA.

Results

Subgroup 1 exhibited elevated levels of pro-inflammatory liver-conjugated secondary bile acids (BAs), glycodeoxycholate and taurolithocholate, and reduced gut microbiota-derived protective secondary BAs, ursodeoxycholate and isoursodeoxycholate, compared to Subgroup 2 (FC>1.5; BH p<0.05). Subgroup 1 showed activation of inflammatory and tissue damage pathways including hepatic fibrosis and cytokine signaling (LPS, TNF, NFKB), but inhibition of homeostasis (LXR/RXR) and metabolic PPAR pathways, and cholesterol and BA regulators (INSIG1, ATP8B1, CYP7B1, and FOXA3) relative to subgroup 2 (-log(BH) p>3, Zscore>2).

Conclusion

These findings extend previously defined subgroup differences, with BA dysregulation as a key feature. Given the dependence of BA homeostasis on liver-gut microbiota interactions, these results suggest the presence of a putative liver-gut-pancreas axis that may contribute to biological heterogeneity in T1D and warrants further mechanistic investigation. Disclosure A. Bedrat: None. N.A. Truchan: None. S. Jia: None. M. Roethle: None. M.J. Hessner: None. Funding NIDDK (R01DK125014)NIDDK (R01DK121528)

Zitieren

APA

BEDRAT, A., TRUCHAN, N. A., JIA, S., ROETHLE, M., & HESSNER, M. J. (2026). 1024-OR: Immunologically Distinct Type 1 Diabetes Subgroups Exhibit Divergent Metabolomic Profiles. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-1024-or

Vancouver

BEDRAT A, TRUCHAN NA, JIA S, ROETHLE M, HESSNER MJ. 1024-OR: Immunologically Distinct Type 1 Diabetes Subgroups Exhibit Divergent Metabolomic Profiles. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-1024-or

BibTeX
@article{BEDRAT2026,
  author = {BEDRAT, AMINA and TRUCHAN, NATHAN A. and JIA, SHUANG and ROETHLE, MARK and HESSNER, MARTIN J.},
  title = {1024-OR: Immunologically Distinct Type 1 Diabetes Subgroups Exhibit Divergent Metabolomic Profiles},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-1024-or}
}
Kostenlos starten →